The global ammunition market size is calculated at USD 37.24 billion in 2025 and is forecasted to reach around USD 51.93 billion by 2034, accelerating at a CAGR of 3.78% from 2025 to 2034. The North America ammunition market size surpassed USD 11.11 billion in 2024 and is expanding at a CAGR of 3.95% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. Ammunition Market, by Caliber,
7.1.1. Small
7.1.1.1. Market Revenue and Forecast
7.1.2. Medium
7.1.2.1. Market Revenue and Forecast
7.1.3. Large
7.1.3.1. Market Revenue and Forecast
7.1.4. Artillery
7.1.4.1. Market Revenue and Forecast
7.1.5. Mortar
7.1.5.1. Market Revenue and Forecast
8.1. Ammunition Market, by Product,
8.1.1. Rimfire
8.1.1.1. Market Revenue and Forecast
8.1.2. Centrefire
8.1.2.1. Market Revenue and Forecast
9.1. Ammunition Market, by End User,
9.1.1. Civil & Commercial
9.1.1.1. Market Revenue and Forecast
9.1.2. Defense
9.1.2.1. Market Revenue and Forecast
10.1. Ammunition Market, by Component,
10.1.1. Fuses & Primers
10.1.1.1. Market Revenue and Forecast
10.1.2. Gun Powder
10.1.2.1. Market Revenue and Forecast
10.1.3. Projectile
10.1.3.1. Market Revenue and Forecast
10.1.4. Cases
10.1.4.1. Market Revenue and Forecast
10.1.5. Others
10.1.5.1. Market Revenue and Forecast
11.1. Ammunition Market, by Type,
11.1.1. Bullets
11.1.1.1. Market Revenue and Forecast
11.1.2. Aerial Bombs
11.1.2.1. Market Revenue and Forecast
11.1.3. Grenades
11.1.3.1. Market Revenue and Forecast
11.1.4. Mortars
11.1.4.1. Market Revenue and Forecast
11.1.5. Artillery Shells
11.1.5.1. Market Revenue and Forecast
11.1.5. Others
11.1.5.1. Market Revenue and Forecast
12.1. Ammunition Market, by Guidance,
12.1.1. Guided
12.1.1.1. Market Revenue and Forecast
12.1.2. Non-guided
12.1.2.1. Market Revenue and Forecast
13.1. Ammunition Market, by Lethality,
13.1.1. Lethal
13.1.1.1. Market Revenue and Forecast
13.1.2. Less-lethal
13.1.2.1. Market Revenue and Forecast
14.1. Ammunition Market, by End-Use,
14.1.1. Military & Homeland Security
14.1.1.1. Market Revenue and Forecast
14.1.2. Civil & Commercial
14.1.2.1. Market Revenue and Forecast
14.1.3. Others
14.1.3.1. Market Revenue and Forecast
15.1. North America
15.1.1. Market Revenue and Forecast, by Caliber
15.1.2. Market Revenue and Forecast, by Product
15.1.3. Market Revenue and Forecast, by End User
15.1.4. Market Revenue and Forecast, by Component
15.1.5. Market Revenue and Forecast, by Type
15.1.6. Market Revenue and Forecast, by Guidance
15.1.7. Market Revenue and Forecast, by Lethality
15.1.8. Market Revenue and Forecast, by End-Use
15.1.9. U.S.
15.1.9.1. Market Revenue and Forecast, by Caliber
15.1.9.2. Market Revenue and Forecast, by Product
15.1.9.3. Market Revenue and Forecast, by End User
15.1.9.4. Market Revenue and Forecast, by Component
15.1.9.5. Market Revenue and Forecast, by Type
15.1.9.6. Market Revenue and Forecast, by Guidance
15.1.9.7. Market Revenue and Forecast, by Lethality
15.1.9.8. Market Revenue and Forecast, by End-Use
15.1.10. Rest of North America
15.1.10.1. Market Revenue and Forecast, by Caliber
15.1.10.2. Market Revenue and Forecast, by Product
15.1.10.3. Market Revenue and Forecast, by End User
15.1.10.4. Market Revenue and Forecast, by Component
15.1.10.5. Market Revenue and Forecast, by Type
15.1.10.6. Market Revenue and Forecast, by Guidance
15.1.10.7. Market Revenue and Forecast, by Lethality
15.1.10.8. Market Revenue and Forecast, by End-Use
15.2. Europe
15.2.1. Market Revenue and Forecast, by Caliber
15.2.2. Market Revenue and Forecast, by Product
15.2.3. Market Revenue and Forecast, by End User
15.2.4. Market Revenue and Forecast, by Component
15.2.5. Market Revenue and Forecast, by Type
15.2.6. Market Revenue and Forecast, by Guidance
15.2.7. Market Revenue and Forecast, by Lethality
15.2.8. Market Revenue and Forecast, by End-Use
15.2.9. UK
15.2.9.1. Market Revenue and Forecast, by Caliber
15.2.9.2. Market Revenue and Forecast, by Product
15.2.9.3. Market Revenue and Forecast, by End User
15.2.9.4. Market Revenue and Forecast, by Component
15.2.9.5. Market Revenue and Forecast, by Type
15.2.9.6. Market Revenue and Forecast, by Guidance
15.2.9.7. Market Revenue and Forecast, by Lethality
15.2.9.8. Market Revenue and Forecast, by End-Use
15.2.10. Germany
15.2.10.1. Market Revenue and Forecast, by Caliber
15.2.10.2. Market Revenue and Forecast, by Product
15.2.10.3. Market Revenue and Forecast, by End User
15.2.10.4. Market Revenue and Forecast, by Component
15.2.10.5. Market Revenue and Forecast, by Type
15.2.10.6. Market Revenue and Forecast, by Guidance
15.2.10.7. Market Revenue and Forecast, by Lethality
15.2.10.8. Market Revenue and Forecast, by End-Use
15.2.11. France
15.2.11.1. Market Revenue and Forecast, by Caliber
15.2.11.2. Market Revenue and Forecast, by Product
15.2.11.3. Market Revenue and Forecast, by End User
15.2.11.4. Market Revenue and Forecast, by Component
15.2.11.5. Market Revenue and Forecast, by Type
15.2.11.6. Market Revenue and Forecast, by Guidance
15.2.11.7. Market Revenue and Forecast, by End-Use
15.2.11.8. Market Revenue and Forecast, by Lethality
15.2.12. Rest of Europe
15.2.12.1. Market Revenue and Forecast, by Caliber
15.2.12.2. Market Revenue and Forecast, by Product
15.2.12.3. Market Revenue and Forecast, by End User
15.2.12.4. Market Revenue and Forecast, by Component
15.2.12.5. Market Revenue and Forecast, by Type
15.2.12.6. Market Revenue and Forecast, by Guidance
15.2.12.7. Market Revenue and Forecast, by Lethality
15.2.12.8. Market Revenue and Forecast, by End-Use
15.3. APAC
15.3.1. Market Revenue and Forecast, by Caliber
15.3.2. Market Revenue and Forecast, by Product
15.3.3. Market Revenue and Forecast, by End User
15.3.4. Market Revenue and Forecast, by Component
15.3.5. Market Revenue and Forecast, by Type
15.3.6. Market Revenue and Forecast, by Guidance
15.3.7. Market Revenue and Forecast, by Lethality
15.3.8. Market Revenue and Forecast, by End-Use
15.3.9. India
15.3.9.1. Market Revenue and Forecast, by Caliber
15.3.9.2. Market Revenue and Forecast, by Product
15.3.9.3. Market Revenue and Forecast, by End User
15.3.9.4. Market Revenue and Forecast, by Component
15.3.9.5. Market Revenue and Forecast, by Type
15.3.9.6. Market Revenue and Forecast, by Guidance
15.3.9.7. Market Revenue and Forecast, by Lethality
15.3.9.8. Market Revenue and Forecast, by End-Use
15.3.10. China
15.3.10.1. Market Revenue and Forecast, by Caliber
15.3.10.2. Market Revenue and Forecast, by Product
15.3.10.3. Market Revenue and Forecast, by End User
15.3.10.4. Market Revenue and Forecast, by Component
15.3.10.5. Market Revenue and Forecast, by Type
15.3.10.6. Market Revenue and Forecast, by Guidance
15.3.10.7. Market Revenue and Forecast, by Lethality
15.3.10.8. Market Revenue and Forecast, by End-Use
15.3.11. Japan
15.3.11.1. Market Revenue and Forecast, by Caliber
15.3.11.2. Market Revenue and Forecast, by Product
15.3.11.3. Market Revenue and Forecast, by End User
15.3.11.4. Market Revenue and Forecast, by Component
15.3.11.5. Market Revenue and Forecast, by Type
15.3.11.6. Market Revenue and Forecast, by Guidance
15.3.11.7. Market Revenue and Forecast, by Lethality
15.3.11.8. Market Revenue and Forecast, by End-Use
15.3.12. Rest of APAC
15.3.12.1. Market Revenue and Forecast, by Caliber
15.3.12.2. Market Revenue and Forecast, by Product
15.3.12.3. Market Revenue and Forecast, by End User
15.3.12.4. Market Revenue and Forecast, by Component
15.3.12.5. Market Revenue and Forecast, by Type
15.3.12.6. Market Revenue and Forecast, by Guidance
15.3.12.7. Market Revenue and Forecast, by Lethality
15.3.12.8. Market Revenue and Forecast, by End-Use
15.4. MEA
15.4.1. Market Revenue and Forecast, by Caliber
15.4.2. Market Revenue and Forecast, by Product
15.4.3. Market Revenue and Forecast, by End User
15.4.4. Market Revenue and Forecast, by Component
15.4.5. Market Revenue and Forecast, by Type
15.4.6. Market Revenue and Forecast, by Guidance
15.4.7. Market Revenue and Forecast, by Lethality
15.4.8. Market Revenue and Forecast, by End-Use
15.4.9. GCC
15.4.9.1. Market Revenue and Forecast, by Caliber
15.4.9.2. Market Revenue and Forecast, by Product
15.4.9.3. Market Revenue and Forecast, by End User
15.4.9.4. Market Revenue and Forecast, by Component
15.4.9.5. Market Revenue and Forecast, by Type
15.4.9.6. Market Revenue and Forecast, by Guidance
15.4.9.7. Market Revenue and Forecast, by Lethality
15.4.9.8. Market Revenue and Forecast, by End-Use
15.4.10. North Africa
15.4.10.1. Market Revenue and Forecast, by Caliber
15.4.10.2. Market Revenue and Forecast, by Product
15.4.10.3. Market Revenue and Forecast, by End User
15.4.10.4. Market Revenue and Forecast, by Component
15.4.10.5. Market Revenue and Forecast, by Type
15.4.10.6. Market Revenue and Forecast, by Guidance
15.4.10.7. Market Revenue and Forecast, by Lethality
15.4.10.8. Market Revenue and Forecast, by End-Use
15.4.11. South Africa
15.4.11.1. Market Revenue and Forecast, by Caliber
15.4.11.2. Market Revenue and Forecast, by Product
15.4.11.3. Market Revenue and Forecast, by End User
15.4.11.4. Market Revenue and Forecast, by Component
15.4.11.5. Market Revenue and Forecast, by Type
15.4.11.6. Market Revenue and Forecast, by Guidance
15.4.11.7. Market Revenue and Forecast, by Lethality
15.4.11.8. Market Revenue and Forecast, by End-Use
15.4.12. Rest of MEA
15.4.12.1. Market Revenue and Forecast, by Caliber
15.4.12.2. Market Revenue and Forecast, by Product
15.4.12.3. Market Revenue and Forecast, by End User
15.4.12.4. Market Revenue and Forecast, by Component
15.4.12.5. Market Revenue and Forecast, by Type
15.4.12.6. Market Revenue and Forecast, by Guidance
15.4.12.7. Market Revenue and Forecast, by Lethality
15.4.12.8. Market Revenue and Forecast, by End-Use
15.5. Latin America
15.5.1. Market Revenue and Forecast, by Caliber
15.5.2. Market Revenue and Forecast, by Product
15.5.3. Market Revenue and Forecast, by End User
15.5.4. Market Revenue and Forecast, by Component
15.5.5. Market Revenue and Forecast, by Type
15.5.6. Market Revenue and Forecast, by Guidance
15.5.7. Market Revenue and Forecast, by Lethality
15.5.8. Market Revenue and Forecast, by End-Use
15.5.9. Brazil
15.5.9.1. Market Revenue and Forecast, by Caliber
15.5.9.2. Market Revenue and Forecast, by Product
15.5.9.3. Market Revenue and Forecast, by End User
15.5.9.4. Market Revenue and Forecast, by Component
15.5.9.5. Market Revenue and Forecast, by Type
15.5.9.6. Market Revenue and Forecast, by Guidance
15.5.9.7. Market Revenue and Forecast, by Lethality
15.5.9.8. Market Revenue and Forecast, by End-Use
15.5.10. Rest of LATAM
15.5.10.1. Market Revenue and Forecast, by Caliber
15.5.10.2. Market Revenue and Forecast, by Product
15.5.10.3. Market Revenue and Forecast, by End User
15.5.10.4. Market Revenue and Forecast, by Component
15.5.10.5. Market Revenue and Forecast, by Type
15.5.10.6. Market Revenue and Forecast, by Guidance
15.5.10.7. Market Revenue and Forecast, by Lethality
15.5.10.8. Market Revenue and Forecast, by End-Use
16.1. Northrop Grumman Corporation
16.1.1. Company Overview
16.1.2. Product Offerings
16.1.3. Financial Performance
16.1.4. Recent Initiatives
16.2. FN Herstal
16.2.1. Company Overview
16.2.2. Product Offerings
16.2.3. Financial Performance
16.2.4. Recent Initiatives
16.3. Olin Corporation
16.3.1. Company Overview
16.3.2. Product Offerings
16.3.3. Financial Performance
16.3.4. Recent Initiatives
16.4. General Dynamics Corporation
16.4.1. Company Overview
16.4.2. Product Offerings
16.4.3. Financial Performance
16.4.4. Recent Initiatives
16.5. BAE Systems, Inc.
16.5.1. Company Overview
16.5.2. Product Offerings
16.5.3. Financial Performance
16.5.4. Recent Initiatives
16.6. Rheinmetall Defense
16.6.1. Company Overview
16.6.2. Product Offerings
16.6.3. Financial Performance
16.6.4. Recent Initiatives
16.7. Nexter KNDS Group
16.7.1. Company Overview
16.7.2. Product Offerings
16.7.3. Financial Performance
16.7.4. Recent Initiatives
16.8. Hanwha Corporation
16.8.1. Company Overview
16.8.2. Product Offerings
16.8.3. Financial Performance
16.8.4. Recent Initiatives
16.9. ST Engineering
16.9.1. Company Overview
16.9.2. Product Offerings
16.9.3. Financial Performance
16.9.4. Recent Initiatives
16.10. Remington Arms Company LLC
16.10.1. Company Overview
16.10.2. Product Offerings
16.10.3. Financial Performance
16.10.4. Recent Initiatives
16.7. Primary Research
16.7. Secondary Research
16.7. Assumptions
18.1. About Us
18.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample